Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis ; volume:7 ; number:1 ; day:6 ; month:4 ; year:2010 ; pages:1-8 ; date:12.2010
Journal of neuroinflammation ; 7, Heft 1 (6.4.2010), 1-8, 12.2010
- Urheber
-
Tenorio-Laranga, Jofre
- Beteiligte Personen und Organisationen
-
Coret-Ferrer, Francisco
Casanova-Estruch, Buenaventura
Burgal, María
García-Horsman, J Arturo
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-7-23
- URN
-
urn:nbn:de:1111-2016032327540
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tenorio-Laranga, Jofre
- Coret-Ferrer, Francisco
- Casanova-Estruch, Buenaventura
- Burgal, María
- García-Horsman, J Arturo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relapsing/remitting type 1 diabetes
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
Longitudinal structural network reorganisation in early relapsing-remitting multiple sclerosis [Abstract]
Relapsing/remitting type 1 diabetes
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
Longitudinal structural network reorganisation in early relapsing-remitting multiple sclerosis [Abstract]
Relapsing/remitting type 1 diabetes
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis